114 related articles for article (PubMed ID: 17202839)
1. zVAD-fmk, unlike BocD-fmk, does not inhibit caspase-6 acting on 14-3-3/Bad pathway in apoptosis of p815 mastocytoma cells.
Yee SB; Baek SJ; Park HT; Jeong SH; Jeong JH; Kim TH; Kim JM; Jeong BK; Park BS; Kwon TK; Yoon I; Yoo YH
Exp Mol Med; 2006 Dec; 38(6):634-42. PubMed ID: 17202839
[TBL] [Abstract][Full Text] [Related]
2. Denbinobin induces apoptosis in human lung adenocarcinoma cells via Akt inactivation, Bad activation, and mitochondrial dysfunction.
Kuo CT; Hsu MJ; Chen BC; Chen CC; Teng CM; Pan SL; Lin CH
Toxicol Lett; 2008 Feb; 177(1):48-58. PubMed ID: 18262737
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of Bcl-2 over-expression and ZVAD.FMK treatment on dexamethasone and VP16-induced apoptosis in CEM cells.
Benson RS; Dive C; Watson AJ
Cell Death Differ; 1998 May; 5(5):432-9. PubMed ID: 10200493
[TBL] [Abstract][Full Text] [Related]
4. zVAD-fmk upregulates caspase-9 cleavage and activity in etoposide-induced cell death of mouse embryonic fibroblasts.
Rodríguez-Enfedaque A; Delmas E; Guillaume A; Gaumer S; Mignotte B; Vayssière JL; Renaud F
Biochim Biophys Acta; 2012 Aug; 1823(8):1343-52. PubMed ID: 22613767
[TBL] [Abstract][Full Text] [Related]
5. Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation.
Emamaullee JA; Stanton L; Schur C; Shapiro AM
Diabetes; 2007 May; 56(5):1289-98. PubMed ID: 17303806
[TBL] [Abstract][Full Text] [Related]
6. A ginseng saponin metabolite-induced apoptosis in HepG2 cells involves a mitochondria-mediated pathway and its downstream caspase-8 activation and Bid cleavage.
Oh SH; Lee BH
Toxicol Appl Pharmacol; 2004 Feb; 194(3):221-9. PubMed ID: 14761678
[TBL] [Abstract][Full Text] [Related]
7. Caspase inhibition reduces apoptotic death of cryopreserved porcine hepatocytes.
Yagi T; Hardin JA; Valenzuela YM; Miyoshi H; Gores GJ; Nyberg SL
Hepatology; 2001 Jun; 33(6):1432-40. PubMed ID: 11391532
[TBL] [Abstract][Full Text] [Related]
8. Caspase-dependent and -independent apoptosis of mast cells induced by withdrawal of IL-3 is prevented by Toll-like receptor 4-mediated lipopolysaccharide stimulation.
Yoshikawa H; Tasaka K
Eur J Immunol; 2003 Aug; 33(8):2149-59. PubMed ID: 12884289
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of interleukin-2-and interleukin-4-mediated early activation of normal human B lymphocytes by the caspase inhibitor zVAD-fmk.
Mouhamad S; Arnoult D; Auffredou MT; Estaquier J; Vazquez A
Eur Cytokine Netw; 2002; 13(4):439-45. PubMed ID: 12517729
[TBL] [Abstract][Full Text] [Related]
10. Caspase inhibitor zVAD.fmk reduces infarct size after myocardial ischaemia and reperfusion in rats but not in mice.
Mersmann J; Zacharowski PA; Schmitz I; Zacharowski K
Resuscitation; 2008 Dec; 79(3):468-74. PubMed ID: 18805622
[TBL] [Abstract][Full Text] [Related]
11. Genistein-induced apoptosis of p815 mastocytoma cells is mediated by Bax and augmented by a proteasome inhibitor, lactacystin.
Park BS; Baek SJ; Song KH; Kim KH; Jeong SJ; Jeong MH; Seo SY; Lee SW; Yoo KS; Yoo YH
Nutr Cancer; 2002; 42(2):248-55. PubMed ID: 12416267
[TBL] [Abstract][Full Text] [Related]
12. Improvement of the survival rate after rat massive hepatectomy due to the reduction of apoptosis by caspase inhibitor.
Yoshida N; Iwata H; Yamada T; Sekino T; Matsuo H; Shirahashi K; Miyahara T; Kiyama S; Takemura H
J Gastroenterol Hepatol; 2007 Nov; 22(11):2015-21. PubMed ID: 17559362
[TBL] [Abstract][Full Text] [Related]
13. p38 MAPK mediates TNF-induced apoptosis in endothelial cells via phosphorylation and downregulation of Bcl-x(L).
Grethe S; Ares MP; Andersson T; Pörn-Ares MI
Exp Cell Res; 2004 Aug; 298(2):632-42. PubMed ID: 15265709
[TBL] [Abstract][Full Text] [Related]
14. Activation of an alternative death receptor-induced signaling pathway in human hepatocytes under caspase arrest.
Dünstl G; Weiland T; Schlaeger C; Nüssler A; Künstle G; Wendel A
Arch Biochem Biophys; 2007 Jun; 462(2):140-9. PubMed ID: 17466932
[TBL] [Abstract][Full Text] [Related]
15. LIGHT sensitizes IFN-gamma-mediated apoptosis of HT-29 human carcinoma cells through both death receptor and mitochondria pathways.
Zhang MC; Liu HP; Demchik LL; Zhai YF; Yang DJ
Cell Res; 2004 Apr; 14(2):117-24. PubMed ID: 15115612
[TBL] [Abstract][Full Text] [Related]
16. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2.
Dirsch VM; Stuppner H; Vollmar AM
Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221
[TBL] [Abstract][Full Text] [Related]
17. In vivo myocardial infarct size reduction by a caspase inhibitor administered after the onset of ischemia.
Huang JQ; Radinovic S; Rezaiefar P; Black SC
Eur J Pharmacol; 2000 Aug; 402(1-2):139-42. PubMed ID: 10940367
[TBL] [Abstract][Full Text] [Related]
18. Novel mechanisms of apoptosis induced by histone deacetylase inhibitors.
Peart MJ; Tainton KM; Ruefli AA; Dear AE; Sedelies KA; O'Reilly LA; Waterhouse NJ; Trapani JA; Johnstone RW
Cancer Res; 2003 Aug; 63(15):4460-71. PubMed ID: 12907619
[TBL] [Abstract][Full Text] [Related]
19. Alterations in protein expression in HL-60 cells during etoposide-induced apoptosis modulated by the caspase inhibitor ZVAD.fmk.
Navakauskiene R; Treigyte G; Savickiene J; Gineitis A; Magnusson KE
Ann N Y Acad Sci; 2004 Dec; 1030():393-402. PubMed ID: 15659822
[TBL] [Abstract][Full Text] [Related]
20. Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes deltapsim loss, caspase-9 activity, and apoptosis in Jurkat cells.
Gamen S; Anel A; Pérez-Galán P; Lasierra P; Johnson D; Piñeiro A; Naval J
Exp Cell Res; 2000 Jul; 258(1):223-35. PubMed ID: 10912804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
